• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeCutting EdgeReading the signs

Reading the signs

Anna Wagstaff

1 March 2011 Cutting Edge 0

Number 41

Download pdf article

The concept of a genomic signature that can define any tumour according to its unique biology has been central to the emerging paradigm of personalised therapy. But how helpful are multi-gene assays in guiding treatment decisions in clinical practice?

Download full article

  • genomic signitures
  • MammaPrint
  • multi gene assays
  • Oncotype DX
Previous article
Next article

Related Articles

Cover Story

Laura van ‘t Veer: the person behind personalised treatments

Cover Story 1 May 2006 0
Editorial

No easy road to outsmart cancer

Editorial 1 July 2015 0
No Picture
Drug Watch

Bringing personalised cancer treatments to the people

Drug Watch 1 May 2007 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy